MITOCHONDRIAL DISORDERS AND THEIR CORRECTION IN NEUROLOGICAL DISEASES

被引:0
|
作者
Sidorova, Olga [1 ]
机构
[1] Moscow Reg Res Clin Inst MONIKI, Moscow, Russia
来源
关键词
Sense of belonging; Scale; Adolescents; IDEBENONE; EFFICACY;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Mitochondria are cellular organelles that produce energy in the form of ATP. For this reason, they are called "power stations" or "energy factories". Mitochondria have their DNA. Part of mitochondrial DNA in the process of phylogenesis moved into nuclear DNA. There are 4 types of metabolism in mitochondria: a) Transfer of electrons in the respiratory chain with the formation of ATP and oxygen, b) Fat metabolism with the participation of carnitine, c) Amino acid metabolism, d) Carbohydrate metabolism. There are 2 groups of mitochondrial pathology: Primary mitochondrial pathology is hereditary syndromes caused by mutations in genes responsible for mitochondrial proteins (Kearns-Sayre syndrome, Pearson syndrome, MELAS syndrome, MERRF syndrome, and others). Secondary mitochondrial pathology includes dysfunction of mitochondria as an important link in pathogenesis. Primary mitochondrial diseases are caused by mutations in mitochondrial DNA or nuclear DNA that affect the respiratory chain or mtDNA homeostasis. Secondary mitochondrial disorders have been identified in common sporadic neurological diseases, including Alzheimer's disease, Parkinson's disease, and other pathologies.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [21] Voice disorders caused by neurological diseases
    Gamboa, J
    Jiménez-Jiménez, FJ
    Mate, MA
    Cobeta, I
    [J]. REVISTA DE NEUROLOGIA, 2001, 33 (02) : 153 - 168
  • [22] Depressive disorders in internal and neurological diseases
    Juckel, G.
    Norra, C.
    Herpertz, S.
    Baghai, T. C.
    Lieb, M.
    Schaefer, M.
    [J]. NERVENHEILKUNDE, 2013, 32 (06) : 381 - 387
  • [23] Skin disorders and neurological diseases - Presentation
    VazquezDorval, FJ
    [J]. REVISTA DE NEUROLOGIA, 1997, 25 : S205 - S206
  • [24] Neurological disorders and inflammatory bowel diseases
    Giovanni Casella
    Gian Eugenio Tontini
    Gabrio Bassotti
    Luca Pastorelli
    Vincenzo Villanacci
    Luisa Spina
    Vittorio Baldini
    Maurizio Vecchi
    [J]. World Journal of Gastroenterology, 2014, 20 (27) : 8764 - 8782
  • [25] Correction to: White matter and neurological disorders
    Han-Gyu Bae
    Tai Kyoung Kim
    Ho Young Suk
    Sangyong Jung
    Dong-Gyu Jo
    [J]. Archives of Pharmacal Research, 2021, 44 (3) : 322 - 322
  • [26] Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics
    Ul Nabi, Showkat
    Rehman, Muneeb U.
    Arafah, Azher
    Taifa, Syed
    Khan, Iqra Shafi
    Khan, Andleeb
    Rashid, Summya
    Jan, Fatimah
    Wani, Hilal Ahmad
    Ahmad, Sheikh Fayaz
    [J]. CURRENT NEUROPHARMACOLOGY, 2023, 21 (05) : 1042 - 1064
  • [27] Sleep Disorders in Mitochondrial Diseases
    Valerio Brunetti
    Giacomo Della Marca
    Serenella Servidei
    Guido Primiano
    [J]. Current Neurology and Neuroscience Reports, 2021, 21
  • [28] RESVERATROL FOR THE CORRECTION OF MITOCHONDRIAL DISORDERS
    Costa, Lopes A.
    Boneh, A.
    Tarnopolsky, M.
    Thorburn, D.
    Rotig, A.
    Bastin, J.
    Djouadi, F.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S157 - S157
  • [29] Sleep Disorders in Mitochondrial Diseases
    Brunetti, Valerio
    Della Marca, Giacomo
    Servidei, Serenella
    Primiano, Guido
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [30] Movement disorders in mitochondrial diseases
    Tranchant, C.
    Anheim, M.
    [J]. REVUE NEUROLOGIQUE, 2016, 172 (8-9) : 524 - 529